Characteristics | Â | Unadjusted | Adjusted analysis model1 | Adjusted analysis model2 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | OR | 95% CI | p-value | ||
Sex | male (ref) | 1.00 | Â | Â | 1.00 | Â | Â | 1.00 | Â | Â |
female | 2.40 | 1.42-4.06 | 0.001* | 2.28 | 1.23-4.22 | 0.009* | 2.29 | 1.19-4.42 | 0.013* | |
Age (years) | <50 (ref) | 1.00 | Â | Â | 1.00 | Â | Â | 1.00 | Â | Â |
50-59 | 1.98 | 0.97-4.03 | 0.969 | 1.55 | 0.74-3.26 | 0.958 | 1.81 | 0.84-3.90 | 0.766 | |
60-69 | 2.52 | 1.26-5.04 | 0.162 | 1.79 | 0.82-3.88 | 0.411 | 1.97 | 0.88-4.39 | 0.457 | |
70≤ | 3.14 | 1.57-6.30 | 0.007* | 2.00 | 0.87-4.60 | 0.213 | 2.37 | 0.99-5.66 | 0.150 | |
Marital status | married | 1.46 | 0.92-2.34 | 0.112 | 1.84 | 1.06-3.19 | 0.029* | 1.63 | 0.99-5.66 | 0.093 |
single/others b (ref) | 1.00 | Â | Â | 1.00 | Â | Â | 1.00 | Â | Â | |
Education | ≤ middle | 1.50 | 1.00-2.24 | 0.050 | 1.12 | 0.66-1.89 | 0.670 | 1.63 | 0.92-2.89 | 0.401 |
≥ high (ref) | 1.00 |  |  | 1.00 |  |  |  |  |  | |
Family income (10,000won/month) | ≤100 (ref) | 1.00 |  |  | 1.00 |  |  | 1.00 |  |  |
101-200 | 1.05 | 0.57-1.90 | 0.146 | 1.14 | 0.58-2.21 | 0.265 | 1.04 | 0.73-2.19 | 0.380 | |
201-300 | 0.61 | 0.34-1.07 | 0.159 | 0.73 | 0.37-1.47 | 0.331 | 0.65 | 0.31-1.34 | 0.194 | |
≥301 | 0.60 | 0.36-1.00 | 0.096 | 0.76 | 0.39-1.51 | 0.430 | 0.78 | 0.38-1.60 | 0.660 | |
MMS -total | 0-2(ref) | 1.00 | Â | Â | 1.00 | Â | Â | 1.00 | Â | Â |
3-4 | 6.33 | 0.79-50.87 | 0.358 | 5.01 | 0.61-41.36 | 0.521 | 4.69 | 0.55-40.14 | 0.592 | |
5-6 | 13.72 | 1.81-104.27 | 0.002* | 11.69 | 1.50-91.29 | 0.003* | 11.48 | 1.41-93.30 | 0.003* | |
CROQ-symptoms | 1.03 | 1.02-1.05 | <0.001* | Â | Â | Â | 1.03 | 1.01-1.04 | 0.011* | |
CROQ-physical functioning | 1.01 | 0.99-1.02 | 0.309 | Â | Â | Â | 1.00 | 0.98-1.02 | 0.922 | |
CROQ-psychosocial functioning | 1.01 | 1.00-1.03 | 0.009* | Â | Â | Â | 1.00 | 0.98-1.01 | 0.733 | |
CROQ-cognitive functioning | 1.01 | 1.00-1.03 | 0.046* | Â | Â | Â | 1.00 | 0.99-1.02 | 0.686 | |
CROQ-satisfaction | 1.02 | 1.01-1.04 | <0.001* | Â | Â | Â | 1.02 | 1.00-1.04 | 0.018* | |
CROQ-adverse effects | 1.02 | 1.00-1.04 | 0.017* | Â | Â | Â | 1.02 | 1.00-1.04 | 0.064 |